Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for INVO Fertility (IVF) over the last 16 years, with Q3 2025 value amounting to $1.6 million.

  • INVO Fertility's Cash from Financing Activities rose 83902.48% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 18931.9%. This contributed to the annual value of $3.1 million for FY2024, which is 5780.06% down from last year.
  • Per INVO Fertility's latest filing, its Cash from Financing Activities stood at $1.6 million for Q3 2025, which was up 83902.48% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, INVO Fertility's Cash from Financing Activities ranged from a high of $4.4 million in Q3 2023 and a low of -$169856.0 during Q2 2023
  • For the 5-year period, INVO Fertility's Cash from Financing Activities averaged around $1.4 million, with its median value being $663683.0 (2022).
  • Over the last 5 years, INVO Fertility's Cash from Financing Activities had its largest YoY gain of 1775312.3% in 2023, and its largest YoY loss of 11769.09% in 2023.
  • Over the past 5 years, INVO Fertility's Cash from Financing Activities (Quarter) stood at $3.4 million in 2021, then plummeted by 76.48% to $800000.0 in 2022, then tumbled by 117.69% to -$141527.0 in 2023, then skyrocketed by 449.09% to $494050.0 in 2024, then skyrocketed by 222.09% to $1.6 million in 2025.
  • Its Cash from Financing Activities was $1.6 million in Q3 2025, compared to $1.4 million in Q2 2025 and $3.7 million in Q1 2025.